GUANGJI PHARMA.(SZ:000952) Xin Lang Cai Jing·2025-12-01 05:56Group 1 - The core point of the news is that Guangji Pharmaceutical's stock price increased by 5.22% to 9.87 CNY per share, with a trading volume of 635 million CNY and a turnover rate of 20.39%, resulting in a total market capitalization of 3.422 billion CNY [1] - Guangji Pharmaceutical, established on May 28, 1993, and listed on November 12, 1999, is located in Wuxue City, Hubei Province. The company specializes in the production and sales of pharmaceutical raw materials, veterinary raw materials, feed additives, and fine chemical products [1] - The revenue composition of Guangji Pharmaceutical includes 74.56% from raw material products, 22.97% from formulation products, 1.45% from other products, and 1.02% from supplementary sources [1] Group 2 - Among the top ten circulating shareholders of Guangji Pharmaceutical, one fund from Huaxia Fund, the Huaxia CSI 500 Index Enhanced A (007994), has recently entered the list, holding 2.2814 million shares, which accounts for 0.66% of the circulating shares [2] - The Huaxia CSI 500 Index Enhanced A fund was established on March 25, 2020, with a latest scale of 3.308 billion CNY. It has achieved a year-to-date return of 24.47%, ranking 1946 out of 4207 in its category, and a one-year return of 24.63%, ranking 1851 out of 4009 [2] - The fund manager of Huaxia CSI 500 Index Enhanced A is Sun Meng, who has been in the position for 5 years and 261 days, managing a total fund size of 16.118 billion CNY. During his tenure, the best fund return was 131.64%, while the worst was 20.71% [3]